Interpreting results from biomarker-guided clinical trials: avoiding “negative” or “failed” terminology
Saved in:
| Main Authors: | Nurulamin M. Noor, Haiyan Zheng, David S. Robertson, Joshua Savage, Christina Yap, Andrea L. Jorgensen, James M. S. Wason, on behalf of the MRC-NIHR Trial Methodology Research Partnership (TMRP) Precision Medicine Working Group |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12916-025-04035-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarkers in spinal muscular atrophy
by: Liping Yan, et al.
Published: (2025-07-01) -
Master protocols in vocal biomarker development to reduce variability and advance clinical precision: a narrative review
by: Ayush Kalia, et al.
Published: (2025-06-01) -
Diagnostic biomarkers for active tuberculosis: progress and challenges
by: Betânia M F Nogueira, et al.
Published: (2022-10-01) -
DEFINING CYTOKINES CONTENTS IN SOLVING MAIN CUNICAL ISSUES
by: V. S. Shirinskiy, et al.
Published: (2012-05-01) -
Exploring CISD1 as a multifaceted biomarker in cancer: Implications for diagnosis, prognosis, and immunotherapeutic response
by: Caiyue Li, et al.
Published: (2025-11-01)